Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Concordia International Corp. (NASDAQ: CXRX).

Full DD Report for CXRX

You must become a subscriber to view this report.



Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-06-14N/A0.19N/AN/A0
2018-06-13N/A0.19N/AN/A0
2018-06-12N/A0.19N/AN/A0
2018-06-11N/A0.19N/AN/A0
2018-06-08N/A0.19N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-06-076,29684,1807.4792Cover
2018-06-0615,63365,01124.0467Cover
2018-06-0533,384177,33718.8252Cover
2018-06-0435,617230,76815.4341Cover
2018-06-0116,334105,00115.5560Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on CXRX.


About Concordia International Corp. (NASDAQ: CXRX)

Logo for Concordia International Corp. (NASDAQ: CXRX)

Concordia Healthcare Corporation is a diverse healthcare company focused on the acquisition of legacy pharmaceutical products, medical devices and orphan drugs.

 

Contact Information

 

 

Current Management

  • Mark L. Thompson / President, CEO
  • Wayne Kreppner / COO
  • Adrian de Saldanha / CFO
  • Ron Schmeichel / Chairman
  • Doug Deeth /
  • John Huss /
  • Jordan Kupinsky /
  • Paul Manning /
  • Mark L. Thompson /

Current Share Structure

  • Market Cap: $9,425,209 - 05/15/2018
  • Issue and Outstanding: 28,561,239 - 10/15/2014
  • Float: 11,458,228 - 01/07/2014

 


Recent Filings from (NASDAQ: CXRX)

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: May, 16 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: May, 15 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: May, 10 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: May, 08 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: May, 07 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: May, 04 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: May, 02 2018
Annual and transition report of foreign private issuers under sections 13 or 15(d)
Filing Type: 20-FFiling Source: edgar
Filing Date: March, 08 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: March, 08 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: February, 21 2018

 

 


Daily Technical Chart for (NASDAQ: CXRX)

Daily Technical Chart for (NASDAQ: CXRX)


Stay tuned for daily updates and more on (NASDAQ: CXRX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: CXRX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CXRX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of CXRX and does not buy, sell, or trade any shares of CXRX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/